Skip to content

Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese

Efficiency of Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese Class III

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03517150
Enrollment
60
Registered
2018-05-07
Start date
2016-05-12
Completion date
2018-06-12
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obstructive Sleep Apnea

Brief summary

This study evaluates the effectiveness of intraoral appliance in the treatment of obstructive sleep Apnea Syndrome in class III obese in comparison to an adjustable silicone appliance. Both treatments will be test by all of the participants and they will make the polysomnography exam to have the outcomes.

Interventions

DEVICEmandibular advancement device

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* BMI ≥40 kg/m² and ≤ 49,9 kg/m² * Female and male patients (Both of gender patients) with ages between 20 to 65 years old * Obstructive Sleep Apnea (OSA) diagnosis by polysomnography

Exclusion criteria

* sedative drugs users * Oxygen-dependent or decompensated lung disease * Decompensated congestive heart failure * Signs and symptoms of other sleeping disorders (narcolepsy, restless legs syndrome, insomnia) * craniofacial deformities carriers * previous OSAS Diagnosis and treatment * Active Oncological diseases in the last ten years * Patients with less than 8 teeth per arcade; * Patients with advanced periodontitis;

Design outcomes

Primary

MeasureTime frameDescription
Quality of life10 minutesThe Short-Form 36-Item Health Survey (SF-36) will be used to measure quality of life. This instrument will evaluate the physical health component (PHC) and the mental health component (MHC) through the following dimensions: functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects and mental health.
Daytime sleepiness5 minutesThe Epworth sleepiness scale (ESS) wil measure the subjective daytime sleepiness, assesses the propensity to sleep under inappropriate circumstances. The ESS questionnaire consists of 8 questions about daytime sleepiness in various situations.
Quality of sleep5 minutesThe Pittsburgh Sleep Quality Index is the instrument deployed to evaluate the subjective quality of sleep and the presence of possible disorders. The overall score is formed by the sum of seven components, which can be considered individually, being: 1 - Subjective sleep quality; 2 - sleep latency; 3 - Sleep duration; 4 - Usual efficiency; 5 - Sleep disorders; 6 - Use of sleep medications; 7 - Daytime sleepiness and disturbances during the day. The overall score is formed by the sum of seven components, which can be considered individually, being: 1 - Subjective sleep quality; 2 - sleep latency; 3 - Sleep duration; 4 - Usual efficiency; 5 - Sleep disorders; 6 - Use of sleep medications; 7 - Daytime sleepiness and disturbances during the day. The score is determined by the sum of the seven components, with each answer being given a score between 0 and 3 points. The maximum score of the instrument is 21. The scores\> 5 points indicate poor quality in the sleep pattern.

Secondary

MeasureTime frameDescription
Apnea-hypopnea index (AHI)8 hoursThe obstructive Apnea-hypopnea Index is defined as the mean number of obstructive apneas and hypopneas per hour of sleep, thus: the occurrence of 5 to 14 events per hour of sleep means presence of mild apnea, 15 to 29 moderate apnea and ≥ 30 severe apnea. The AHI is derived from overnight polysomnography.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026